1. Covering the Cover Gastroenterology
Anson W. Lowe, Richard H. Moseley 
Gastroenterology 
Volume 149, Issue 2, Pages (August 2015)
DOI: /j.gastro
Copyright © 2015 AGA Institute Terms and Conditions

2. Figure 1
Fecal infliximab concentrations up to 14 days after IFX therapy for clinical response at week 2, endoscopic response at week 8 and clinical response at 3 months. 3m, 3 months; CR, clinical response; ER, endoscopic response; IFX, infliximab; NR, nonresponse; w2, week 2; w8, week 8.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2015 AGA Institute Terms and Conditions

3. Figure 2
Two- and 6-month overall mortality probability according to the joint-effect model combining the Lille model and MELD score. +, hypothetical patient with a MELD score at 21 and a Lille score at 0.45: 2-month mortality rate is 15.3% and 6-month mortality rate is 23.7%.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2015 AGA Institute Terms and Conditions